Search research articles
Contact Us
Filters
Showing results (211-220 of 265) with videos related to
Page
of 27
Sort By:
Breast Cancer Research and Treatment
|
July 29, 2025
Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective study
Guido Maria Giuffrè, Luisa Carbognin, Giovanna Masone Iacobucci, et al.
Oncotarget
|
November 7, 2015
Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis
Patrizia Vici, Anna Di Benedetto, Cristiana Ercolani, et al.
Breast (Edinburgh, Scotland)
|
June 20, 2017
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation
Luisa Carbognin, Isabella Sperduti, Alessandra Fabi, et al.
Journal of Personalized Medicine
|
August 29, 2024
Outcomes of Radiotherapy in Oligoprogressive Breast Cancer
Fabio Marazzi, Valeria Masiello, Armando Orlandi, et al.
Oncology
|
December 7, 2021
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Alessandra Fabi, Mariangela Ciccarese, Sinome Scagnoli, et al.
American Journal of Clinical Oncology
|
May 22, 2018
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology
Francesco Pasqualetti, Andrea Pace, Alessandra Gonnelli, et al.
Journal of Personalized Medicine
|
December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
Armando Orlandi, Elena Iattoni, Laura Pizzuti, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 19, 2025
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort
Fabio Marazzi, Valeria Masiello, Alessandra Fabi, et al.
NPJ Precision Oncology
|
January 22, 2025
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan
Alessandra Fabi, Alessandro Rossi, Roberta Caputo, et al.
Frontiers in Oncology
|
October 3, 2022
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial
Andrea Antonuzzo, Carla Ida Ripamonti, Fausto Roila, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 265) with videos related to
Sort By:
Page
of 27
Breast Cancer Research and Treatment
|
July 29, 2025
Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective study
Guido Maria Giuffrè, Luisa Carbognin, Giovanna Masone Iacobucci, et al.
Oncotarget
|
November 7, 2015
Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis
Patrizia Vici, Anna Di Benedetto, Cristiana Ercolani, et al.
Breast (Edinburgh, Scotland)
|
June 20, 2017
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation
Luisa Carbognin, Isabella Sperduti, Alessandra Fabi, et al.
Journal of Personalized Medicine
|
August 29, 2024
Outcomes of Radiotherapy in Oligoprogressive Breast Cancer
Fabio Marazzi, Valeria Masiello, Armando Orlandi, et al.
Oncology
|
December 7, 2021
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Alessandra Fabi, Mariangela Ciccarese, Sinome Scagnoli, et al.
American Journal of Clinical Oncology
|
May 22, 2018
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology
Francesco Pasqualetti, Andrea Pace, Alessandra Gonnelli, et al.
Journal of Personalized Medicine
|
December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
Armando Orlandi, Elena Iattoni, Laura Pizzuti, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 19, 2025
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohort
Fabio Marazzi, Valeria Masiello, Alessandra Fabi, et al.
NPJ Precision Oncology
|
January 22, 2025
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan
Alessandra Fabi, Alessandro Rossi, Roberta Caputo, et al.
Frontiers in Oncology
|
October 3, 2022
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial
Andrea Antonuzzo, Carla Ida Ripamonti, Fausto Roila, et al.
Page
of 27